Background*

Ms. S. Louise Phanstiel served as a Partner of Coopers & Lybrand, LLP. Ms. Phanstiel served clients in life and property/casualty insurance, high technology, and higher education at Coopers & Lybrand. She held several important positions at WellPoint, Inc. from 1996 to 2007 and served as its President of Specialty Products from 2003 to 2007. She served as Senior Vice President, and Chief of Staff and Corporate Planning in the Office of the Chairman at WellPoint, Inc. ... from 2000 to 2003. She also served as Senior Vice President, Chief Accounting Officer, Controller, and Chief Financial Officer for all WellPoint, Inc. subsidiaries, including Blue Cross of California from 1996 to 2000. She has been a Director of Verastem, Inc. since September 19, 2012 and Myriad Genetics Inc. since joining on September 16, 2009. She serves as a Director of Cedar Sinai Health System and Cedars-Sinai Medical Center. She served on the Board of Directors at Inveresk Research Group, Inc. and Charles River Laboratories, Inc. Ms. Phanstiel received a B.A. degree in Accounting from the Golden Gate University and is a Certified Public Accountant.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.